Mitochondrial dysfunction has been implicated in aging, cardiovascular disease, cancer, neurodegeneration, and many other pathological conditions or diseases. The inner mitochondrial membrane (IMM) potential (a.k.a.  m ) is essential for ATP synthesis via oxidative phosphorylation and also directly affects levels of reactive oxygen species, apoptosis, thermogenesis, and key signaling pathways. Better understanding the detailed mechanisms by which m regulates cellular function and fate decisions requires tools to manipulate m with spatial and temporal resolution, reversibility, or cell type specificity. To address this need, we have 
Introduction
Mitochondria lie at the crossroad of cellular metabolic and signaling pathways and thus play a pivotal role in regulating many intracellular processes such as energy production, reactive oxygen species (ROS) production, Ca 2+ handling, and cell fate decision (1) . Not surprisingly, defects of mitochondrial function have been implicated in a variety of human maladies such as aging, cardiovascular disease, cancer, and neurodegeneration (2) . The normal functioning of mitochondria largely relies on maintaining the inner membrane potential ( m ) to preserve the protonmotive force necessary to drive oxidative phosphorylation and redox balance. Interestingly, while profound depolarization of  m is detrimental and induces cell injury (3), there is evidence that partial mitochondrial dissipation is cytoprotective (4, 5) . The detailed mechanism underlying the differential regulatory role of  m on cell function and fate remains elusive, partially due to the difficulty of precisely controlling m or mitochondrial membrane permeability (MMP) in an experimental setting. Currently, manipulation of m is mainly via pharmacological intervention, i.e. using chemicals to uncouple the mitochondria (4, 5) or to induce permeability transition pore (mPTP) opening (6) . However, pharmacological approaches often cause unknown side effects and lack the ability to probe spatiotemporal domains. Several research groups, including us, use laser flashes to trigger local or cell wide mitochondrial depolarization via the photooxidation mechanism (7) (8) (9) . A limitation of this approach is that it requires high-energy laser illumination, which may induce uncontrollable oxidative stress and unpredictable outcomes. A new approach capable of precisely controlling MMP or  m is highly desired.
Optogenetics has recently emerged as a technique that utilizes genetically-encoded lightsensitive ion channels, such as channelrhodopsin 2 (ChR2) (10) (11) (12) (13) or halorhodopsin (NpHR) (14, 15) , to precisely and remotely manipulate the activity of cells or animals (10, 12) . ChR2 is a seven-transmembrane domain protein that contains the light-isomerizable chromophore all-transretinal (16) . When excited by blue light, the all-trans retinal undergoes trans-cis isomerization (17) , activating non-selective cationic channels and inducing depolarizing inward currents. Due to its high spatiotemporal resolution, ChR2-based optogenetic techniques have evolved as a powerful tool in basic and translational research. For example, ChR2 has been expressed in neurons (18) to monitor and control their membrane potential, intracellular acidity, calcium influx, and other cellular processes (see ref (13) for a review). In addition, ChR2 has been used to manipulate the membrane excitability of cardiomyocytes (19) (20) (21) , skeletal muscle cells (22) and cell lines expressing voltage-gated ion channels (23, 24) . Despite these advancements, there is few report on the functional expression of ChR2 on the membrane of the mitochondrion, an organelle that requires fine control over ion transport for proper function, until very recently (25, 26) .
In addition to remote control of excitable cells, optogenetics techniques have been used to induce and study cell death. For instance, Yang et al. showed that an optogenetic approach can induce apoptotic cell death in human glioma cells via depolarization of cell membrane potential and influx of Ca 2+ (27) . In another study, Hill et al. reported a two-photon chemical apoptotic targeted ablation technique (28) . By combining this technique with organelle-targeted fluorescent proteins and biosensors, they have successfully achieved precise ablation of specific populations of neurons in the mouse brain. Of note, none of the existing optogenetic approaches directly targets the inner mitochondrial membrane (IMM) permeability to induce cell death. We hypothesize that expression of ChR2 in the IMM of mammalian cells forms functional cationic channels capable of light-induced remote control of m depolarization and manipulation of cell fate decisions. We test this hypothesis using a variety of cell types and our results show that the mitochondrial leading sequence (MLS) of ABCB10, an ATP binding cassette transporter, can target ChR2 into IMM. We demonstrate that this new generation optogenetic approach can be used to induce controlled m depolarization and manipulation of cell fate decisions at high spatial resolution.
Results
Targeting ChR2 to the IMM. The MLS of cytochrome c oxidase subunit VIII (a.k.a. mito) has been widely used to import proteins such as GFP (29) or pericam (30) to mitochondria. Therefore, we first examined its capability to target ChR2 to mitochondria. A mutant of ChR2, ChR2(H134R) (31) , was fused with eYFP and inserted into vector pCMV-myc-mito to generate plasmid mitoChR2(H134R)-eYFP. The construct and the control vectors (mito-eYFP) were transfected to H9C2 cells, respectively. The expressions of ChR2-eYFP and eYFP in mitochondria were examined by staining mitochondria with Mitoracker® Deep Red and analyzing the colocalization of the green and red channels using confocal microscopy. Results show that eYFP was perfectly colocalized with mitochondria ( Fig. S1A ) but ChR2-eYFP was not (Fig. S1B ). In addition, ChR2-eYFP appeared to be improperly processed by the endoplasmic reticulum (ER), implying that the size of the ChR2(H134R)-eYFP precursor might be impairing import. Thus, we next doubled the copy number of mito sequence and constructed plasmid (mito) 2 -ChR2(H134R)-eYFP. However, this modification did not improve the import of ChR2(H134R)-eYFP to mitochondria (data not shown). Thereafter, a series of mito-based ChR2-eYFP plasmids such as mito-ChR2 (H134R)-eYFP-ER (adding ER extraction sequence), mito-ChR2(H134R)(T2-23aa)-eYFP (removing the cell membrane targeting sequence) and (mito)3-ChR2(H134R)-eYFP (to triplicate mito sequence) were constructed. Unfortunately, none of them could efficiently target ChR2-eYFP precursor to the mitochondria (data not shown). We also studied the MLS of ROMK, a candidate of mitochondrial KATP channel located on IMM (32) . Similarly, ROMK MLS successfully imported eYFP into mitochondria (data not shown) but not ChR2-eYFP (Fig. S1C ).
ATP binding cassette (ABC) transporters comprise a large family of membrane translocases (33) and are found in all species from microbe to human (34) . Of them, ABCB10 is an IMM erythroid transporter with an unusually long MLS (140 amino acids) (35) . Studies showed that ABCB10 MLS could lead various membrane proteins to mitochondria (36) , while its depletion targeted ABCB10 to the ER (35) . This MLS was fused with eYFP or ChR2(H134R)-eYFP, to generate ABCB-eYFP and ABCB-ChR2(H134R)-eYFP vectors, respectively, which were then transfected into H9C2 cells. To our great satisfaction, ABCB-eYFP was perfectly localized in mitochondria (Fig. 1A) . Excitingly, ABCB10 MLS successfully translocated ChR2-eYFP precursor into H9C2 mitochondria, as demonstrated by the colocalization of green (eYFP) and red (MitoTracker) channels (Fig. 1B) . Importantly, this method of targeting ChR2 to the IMM did not affect mitochondrial energetics, as demonstrated by the unaltered mitochondrial membrane potential and reactive oxygen species (ROS) level (Fig. S2) . The disposition of ChR2-YFP fusion protein in H9C2 mitochondria was further examined by immunostaining. As shown in figure 1C , the ChR2 protein expression, detected by the ChR2 antibody, was colocalized with MitoTracker.
The capability of ABCB10 MLS to translocate ChR2-eYFP to mitochondria was also confirmed in other cell types such as HeLa cells (Fig. 1D ) and hiPSC-CMs (Fig. 1E) . Altogether, our data demonstrate the localization of ChR2 within the mitochondria.
Light-elicited targeted mitochondrial depolarization. After demonstrating mitochondrial
ChR2 expression, we examined if light could elicit targeted mitochondrial depolarization in ABCBChR2-expressing cells. In an experiment shown in figure 2, H9C2 cells expressing ABCB-ChR2 (fused with eYFP) were split into zone 1 and zone 2, with zone 1 receiving blue (475 nm) LED pulse illuminations and zone 2 receiving no illumination as control ( Fig. 2A) . The change of mitochondrial membrane potential was measured by TMRM using an Olympus confocal microscope (Fig. 2B) . We found that the fluorescence of TMRM faded significantly in cells in zone 1 but not in zone 2 ( Fig. 2C and Video S1). The averaged TMRM intensities before and after light illumination were summarized in figure 2D , which showed that  m in zone 1 cells depolarized by about 80% but in zone 2 cells remained unchanged. In addition to impaired mitochondrial membrane potential, light illumination also caused increased ROS production in ABCB-ChR2 expressing cells, as compared with control or ABCB-ChR2-expressing cells without blue light illumination (Fig S3) . To verify that mitochondrial depolarization in zone 1 cells shown in figure 2 was caused by light-induced activation of ChR2 channels in IMM and not by imaging laserinduced photooxidation and photobleaching, we performed two control experiments. We first examined the effect of confocal imaging light alone on m in ABCB-ChR2-expressing cells. As shown in figure S4A (and Video S2A), in the absence of blue light illumination, confocal laser scanning had no effect on TMRM. However, concurrent application of blue light illumination led to significant  m depolarization (Fig S4B and (Fig 4C) . Importantly, we found that pretreating cells with cyclosporine A, a selective mitochondrial permeability transition pore (mPTP) inhibitor, did not prevent the lightinduced cell death ( Fig 4D) and cytotoxicity (Fig 4E) , indicating that the mitochondrial-targeted optogenetic-mediated cell death is independent of mPTP opening. This finding also denotes that ChR2 proteins formed ion channels in IMM that are functionally like mPTP to elicit cell death. Of note, antioxidants such as MitoTEMPO and MitoQ failed to rescue cells from light-induced cell death (data not shown), suggesting that ROS production is not a crucial factor in mitochondrial optogenetic-mediated cytotoxicity.
We then examined the time and light irradiance dependence of optogenetic-mediated cell death. As shown in figure 5A , viability of cell cultures dropped nearly linearly within 12 hours of light (0.5 mW/mm 2 ) illumination and tapered off slightly thereafter. Regarding the effect of light intensity, we found that six hours of moderate (e.g., 1 mW/mm 2 and 3 mW/mm 2 ) light illumination caused minimal cell death in ABCB-ChR2-expressing cell cultures, as measured by Hoechst and Propidium Iodide (PI) staining (Fig S7) . Increasing light intensity to 5 mW/mm 2 or 7 mW/mm 2 caused a substantial (62% and 82%, respectively) decrease in cell viability (Fig 5B and 5C ).
Importantly, similar intensities (e.g., 3 mW/mm 2 and 5 mW/mm 2 ) of light illumination did not elicit detectable cell death in control cultures (Fig 5B, 5C and Fig S7) .
Molecular mechanisms underlying optogenetic-mediated cell death. To explore the mechanistic pathways underlying the mitochondrial optogenetic-mediated cell death, we treated cells with an apoptosis inhibitor and necroptosis inhibitor, respectively. Cell death analysis showed that Z-VAD-FMK (20µM), a caspase inhibitor, substantially reduced light illuminationinduced cell death, but 7-Cl-O-Nec-1 (100µM), a necroptosis inhibitor, had little effect on cell viability (Fig 6A) , suggesting that the optogenetic-mediated light-induced cell death is likely through the caspase-dependent apoptotic pathway. We also noticed that mitochondrial membrane potentials were less depolarized in Z-VAD-FMK-treated cell cultures upon light illumination (Fig 6B) . The light illumination-elicited activation of the intrinsic apoptosis pathway in ABCB-ChR2-expressing cells was confirmed by cytochrome C release experiments. As shown in figure 6C , immunocytochemistry revealed that cytochrome C was colocalized with TOM20, a mitochondrial outer membrane protein, in both the control cells and ABCB-ChR2-expressing cells not illuminated by LED light. However, light-illuminated ABCB-ChR2-expressing cells showed a punctate/diffuse cytochrome C staining, which was disparate from TOM20 immunostaining, indicating the release of cytochrome C into the cytosol (Fig 6C) . Spatial resolution is especially important for studies of neurons, which have much of their mitochondrial mass located in distal axons or dendrites. There has been considerable debate regarding how neurons handle damaged or dysfunctional mitochondria with some studies concluding that Parkin-mediated mitophagy only occurs near mature lysosomes in the cell body and that retrograde transport is required for degradation of distal mitochondria, while others concluding that Parkin-mediated mitophagy occurs in distal axons without retrograde transport to the soma (40, 41) . Moreover, there may be distinct mechanisms by which neurons handle proximal vs. distal dysfunctional mitochondria and it is important to better define these mechanisms given that mitochondrial dysfunction is implicated in many neurodegenerative diseases and that degeneration of distal axon terminals may be one of the earliest stages and a better therapeutic target (42). The methods described here are ideally suited for investigating this because illumination can selectively depolarize only distal or only proximal mitochondria in vitro or in vivo using fiber optics.
In addition to high spatial resolution, the optogenetics approach provides specific targeting of Apoptosis is a process of programmed cell death that occurs in multicellular organisms. While it is well established that mitochondria play key roles in activating programmed cell death, the underlying detailed mechanisms remain incompletely understood. For instance, the role of inner membrane permeabilization in the execution of pro-apoptotic protein (e.g. cytochrome C) release from the intermembrane space into cytosol is a subject of ongoing controversy. Some studies show that mitochondrial depolarization and IMM permeabilization are required for cytochrome C release and apoptotic cell death (47) . However, others suggest that cytochrome C release can occur in the absence of  m depolarization (48) , mitochondrial depolarization may not be involved in the activation of apoptosis (49) , or PTP opening is a consequence of apoptosis (47) . The disparity may be attributed to the methods used in different studies, such as pharmacological intervention versus genetic manipulation. In the present study, using the mitochondrial optogenetics approach we demonstrate that increased IMM permeability alone is sufficient to trigger apoptotic cell death, which is time and (light) dosage dependent. The activation of intrinsic apoptosis is confirmed by induction of cytochrome C release and prevention of cell death by a caspase inhibitor. Importantly, blocking mPTP did not prevent the light-induced cell death, which provides additional evidence that the expressed ChR2 formed functional cationic pores in IMM.
Importantly, we show that mild short-term light illumination prevented apoptotic cell death in ABCB-ChR2-expressing cells, supporting the notion of mitochondrial preconditioning. Thus, this innovative mitochondrial optogenetics technique can be used to well control IMM depolarization and differentially influence cell fate, a capability not possessed by the existing pharmacological approaches. One limitation of the developed mitochondrial optogenetics technique is that although it enables targeted mitochondrial depolarization at high spatial (cellular or subcellular) resolution, the time resolution of light-induced mitochondrial depolarization is much less. Similar to that shown in a recent study (25) , optogenetic-induced mitochondrial depolarization takes several minutes to accomplish. Using other rhodopsin protein variants with higher conductance or greater light sensitivity may help to achieve better temporal control of mitochondrial depolarization (54) .
Loss-of-function mutations in
The lack of mitochondrial repolarization may be partially due to the slow deactivation of ChR2 channels. Tkatch et al. (25) showed that optogenetic-induced mitochondrial depolarization can recover slowly in cells expressing the ChR(SSFO) mutant. Alternatively, co-expressing Channelrhodopsin and Bacteriorhodopsin or Archaerhodopsins in the IMM and stimulating cells with alternating blue and yellow light might achieve reversible control of  m . The energetic states or types of cell may also affect the feasibility of inducing faster or more reversible mitochondrial depolarization. For instance, mitochondrial oscillations can be readily triggered in isolated guinea pig cardiomyocytes (7, 9) , but it is much more difficult in isolated mouse cardiomyocytes.
In summary, we have developed and characterized a mitochondrial optogenetics approach to induce targeted mitochondrial depolarization, which provides an alternative to the traditional optical or pharmacological means of modulating MMP and  m to understand their roles in determining cell fate. We expect the research tools shown here and the knowledge acquired will facilitate the design of novel optogenetic-based therapeutic strategies for the treatment of diseases involving mitochondrial dysfunction.
Experimental procedures
Cell culture. HeLa and H9C2 cells were obtained from ATCC and cultured in Dulbecco's Modified Eagle Medium (Gibco) supplemented with 10% (v/v) Fetal Bovine Serum (Gibco) and 2 mM LGlutamine (Gibco). Cells were maintained in 5% CO 2 at 37 °C with confluence between 10% and 80%. hiPSC-CMs were reprogrammed from human cardiac fibroblasts as described previously (55) and maintained on Matrigel Membrane Matrix (Thermo Fisher Scientific) in mTeSR™ medium (Stem Cell Technologies) until 75% confluency. CM differentiation was performed by using a small molecule-based protocol as described previously (56, 57) . Beating hiPSC-CM began to appear 9-12 days after differentiation was initiated. Cell death and cytotoxicity assay. ABCB-ChR2-eYFP-expressing or control (i.e., ABCB-eYFP expressing, mock transfected and un-transfected) cells were illuminated by LED light of different duration and irradiance (as indicated in the figure legends). Right after light treatment cells were detached with 0.25% Trypsin-EDTA, stained with Trypan Blue, and counted using a hemocytometer as described previously (24) . The cytotoxicity and cell viability were also measured using the LDH assay and AlamarBlue (AB) assay, respectively. For the LDH assay, at the end of light illumination, 200 l cell culture medium was removed and added to a 96 well plate, 100 l of the reaction mixture was added to each well and the plate was incubated for 30 minutes at room temperature, protected from light. The absorbance was measured at 490nm and 680nm using a microplate reader. LDH activity was calculated following the manufacture's instruction.
For the AB assay, 10 l AlamarBlue reagent was directly added to cells in 100 l culture medium.
Cell cultures were incubated for 4 hours in an incubator (37 o C, protected from light). The absorbance was measured at 570nm using a spectrometer.
Immunocytochemistry. Cells cultured on 15 mm coverslips were fixed in 4% Formaldehyde in PBS and then treated with PBS containing 10% goat serum and 0.3% Triton® X-100 to block nonspecific staining. Cells were stained with the following primary antibodies: ChR2, TOMM20, LC3, ATP5A, or Cytochrome C at a ratio of 1:200. After overnight room temperature incubation, secondary antibodies AlexaFluor 555 and/or AlexaFluor 647 were diluted in 1% BSA, 1% goat serum, 0.3% Triton® X-100 in PBS at a ratio of 1:200, and then added to the cells. Coverslips were mounted on slides and imaged using an Olympus FV1000 confocal microscope. 
